ETV Bharat / bharat

Over 2 lakh genome of SARS-CoV-2 sequenced by INSACOG: Govt

The Indian SARS-CoV-2 Genomics Consortium (INSACOG) being coordinated by the Department of Biotechnology, as of March 23, 2022, has sequenced 2,01,373 SARS-CoV-2 genomes

Over two lakh SARS-CoV-2 genomes have been sequenced by the Indian SARS-COV-2 Genomics Consortia
Over 2 lakh genome of SARS-CoV-2 sequenced by INSACOG: Govt
author img

By

Published : Mar 30, 2022, 6:51 PM IST

New Delhi: Over two lakh SARS-CoV-2 genomes have been sequenced by the Indian SARS-COV-2 Genomics Consortia (INSACOG), the government said on Wednesday. Responding to a question in Lok Sabha, Minister of State for Science and Technology Jitendra Singh said 17 COVID-19 bio-repositories have been notified by the government.

These have been set up at the laboratories of the Department of Biotechnology, the Council of Scientific and Industrial Research, and the Indian Council of Medical Research. "The Indian SARS-CoV-2 Genomics Consortium (INSACOG) being coordinated by the Department of Biotechnology, as of March 23, 2022, has sequenced 2,01,373 SARS-CoV-2 genomes," Singh said in a written response.

New Delhi: Over two lakh SARS-CoV-2 genomes have been sequenced by the Indian SARS-COV-2 Genomics Consortia (INSACOG), the government said on Wednesday. Responding to a question in Lok Sabha, Minister of State for Science and Technology Jitendra Singh said 17 COVID-19 bio-repositories have been notified by the government.

These have been set up at the laboratories of the Department of Biotechnology, the Council of Scientific and Industrial Research, and the Indian Council of Medical Research. "The Indian SARS-CoV-2 Genomics Consortium (INSACOG) being coordinated by the Department of Biotechnology, as of March 23, 2022, has sequenced 2,01,373 SARS-CoV-2 genomes," Singh said in a written response.

Also read: Omicron now dominant variant of SARS-CoV-2 in country

PTI

For All Latest Updates

ETV Bharat Logo

Copyright © 2024 Ushodaya Enterprises Pvt. Ltd., All Rights Reserved.